Literature DB >> 25738779

A case of an anaplastic meningioma metastasizing to the mediastinal lymph nodes.

Norihiro Nishida1, Tsukasa Kanchiku1, Yasuaki Imajo1, Hidenori Suzuki1, Yuichiro Yoshida1, Yoshihiko Kato1, Yoshinobu Hoshii1, Toshihiko Taguchi1.   

Abstract

CONTEXT: Grade II and III (World Health Organization classification) meningiomas rarely develop in the spinal cord. However, we experienced a case with an anaplastic meningioma that developed in the spinal cord at the cervicothoracic junction and metastasized to the mediastinal lymph nodes. No such cases have previously been reported.
FINDINGS: The patient was a 68-year-old man who developed back pain that did not affect his daily living. He developed left lower limb paralysis, and was admitted after magnetic resonance imaging (MRI) revealed an intramedullary tumor at the level of cervical vertebra 7 and thoracic vertebra 1. Positron emission tomography revealed tracer uptake in the intramedullary tumor and the mediastinal lymph nodes, suggesting a metastatic spinal cord tumor or malignant lymphoma. A lymph node biopsy was then performed. Although the tumor was highly malignant, its primary site was not identified. Detailed examinations by several other departments revealed no abnormalities. On hospital day 30, his left lower limb paralysis deteriorated, and MRI revealed that the tumor had grown. Thus, laminaplasty, laminectomy, and tumor resection were performed. The tumor was an anaplastic meningioma that resembled mediastinal lymph node tissue, and other tumor lesions were not found. These findings suggested that an anaplastic meningioma had metastasized to the mediastinal lymph nodes. The patient did not respond to radiotherapy, and he was transferred to another hospital.
CONCLUSION: In cases of intramedullary spinal tumors with metastasis without other potential primary tumor lesions, early diagnosis and treatment should be performed while considering anaplastic meningioma.

Entities:  

Keywords:  Anaplastic meningioma; Lymph nodes; Malignant meningioma; Metastasis; World Health Organization classification

Mesh:

Year:  2016        PMID: 25738779      PMCID: PMC5102288          DOI: 10.1179/2045772315Y.0000000005

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  38 in total

1.  Intrinsic spinal cord tumor resection.

Authors:  Jacques Brotchi
Journal:  Neurosurgery       Date:  2002-05       Impact factor: 4.654

2.  Magnetic resonance imaging of primary spinal intramedullary lymphoma.

Authors:  Tomoki Nakamizo; Haruhisa Inoue; Fukashi Udaka; Masaya Oda; Makoto Kawai; Kengo Uemura; Makio Takahashi; Kazuto Nishinaka; Hideyuki Sawada; Masakuni Kameyama; Tsunemaro Koyama
Journal:  J Neuroimaging       Date:  2002-04       Impact factor: 2.486

Review 3.  Intramedullary meningioma: case report and review of the literature.

Authors:  M Salvati; M Artico; P Lunardi; F M Gagliardi
Journal:  Surg Neurol       Date:  1992-01

4.  MR findings in spinal hemangioblastoma: correlation with symptoms and with angiographic and surgical findings.

Authors:  B C Chu; S Terae; K Hida; M Furukawa; S Abe; K Miyasaka
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 5.  New insights into meningioma: from genetics to trials.

Authors:  Andrej Vranic; Matthieu Peyre; Michel Kalamarides
Journal:  Curr Opin Oncol       Date:  2012-11       Impact factor: 3.645

6.  Spinal cord ependymoma: radical surgical resection and outcome.

Authors:  Fadi Hanbali; Daryl R Fourney; Eric Marmor; Dima Suki; Laurence D Rhines; Jeffrey S Weinberg; Ian E McCutcheon; Ian Suk; Ziya L Gokaslan
Journal:  Neurosurgery       Date:  2002-11       Impact factor: 4.654

7.  Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.

Authors:  E B Hug; A Devries; A F Thornton; J E Munzenride; F S Pardo; E T Hedley-Whyte; M R Bussiere; R Ojemann
Journal:  J Neurooncol       Date:  2000-06       Impact factor: 4.130

8.  Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.

Authors:  U M Schrell; M G Rittig; M Anders; U H Koch; R Marschalek; F Kiesewetter; R Fahlbusch
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

9.  Spinal cord ependymomas: a retrospective analysis of 59 cases.

Authors:  J N Waldron; N J Laperriere; L Jaakkimainen; W J Simpson; D Payne; M Milosevic; C S Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-09-30       Impact factor: 7.038

10.  Spinal meningiomas: critical review of 131 surgically treated patients.

Authors:  I Erol Sandalcioglu; Anja Hunold; Oliver Müller; Hischam Bassiouni; Dietmar Stolke; Siamak Asgari
Journal:  Eur Spine J       Date:  2008-05-15       Impact factor: 3.134

View more
  4 in total

1.  Delayed solitary mediastinal lymph node metastasis from a benign meningothelial meningioma six years after surgical resection of an intracranial tumor.

Authors:  Jae Wan Jung; Chul Park
Journal:  Thorac Cancer       Date:  2021-05-07       Impact factor: 3.500

2.  A rare subtype of meningioma: Case series of anaplastic meningioma and review of the literature.

Authors:  Hongyi Cao; Biying Jiang; Yang Zhao; Chuifeng Fan
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

3.  Malignant meningioma with jugular vein invasion and carotid artery extension: A case report and review of the literature.

Authors:  Hui-Ying Chen; Feng Zhao; Jiang-Yuan Qin; Hai-Mei Lin; Ji-Ping Su
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

Review 4.  Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3.

Authors:  Vincenzo Di Nunno; Caterina Giannini; Sofia Asioli; Alfredo Conti; Julia Furtner; Damiano Balestrini; Alicia Tosoni
Journal:  Cancers (Basel)       Date:  2022-09-26       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.